TRANSCODE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
TRANSCODE THERAPEUTICS, INC. (RNAZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 67 shares for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-14
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 4.00 shares, a 99.98% decline year-over-year.
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was -401.00 shares, a 249.07% decline year-over-year.
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 464.00 shares, a 12.08% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 83.00 shares, a 591.67% increase from fiscal 2023.
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 12.00 shares.
- TRANSCODE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 78.98K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-14 | 4.00 shares derived: sum of 2 quarters · filed 2026-08-14 | -397.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 67.00 shares 10-Q · filed 2026-08-14 | ||
| 2025-09-30 | 4.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -397.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 67.00 shares 10-Q · filed 2025-11-14 | -19.01K shares derived: sum of 4 quarters · filed 2026-04-15 | ||
| 2025-06-30 | -401.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 63.00 shares 10-Q · filed 2025-08-14 | -19.02K shares derived: sum of 3 quarters · filed 2026-04-15 | -537.00 shares derived: sum of 4 quarters · filed 2026-04-15 | ||
| 2025-03-31 | 464.00 shares 10-Q · filed 2025-05-14 | -18.62K shares derived: sum of 2 quarters · filed 2026-04-15 | -136.00 shares derived: sum of 3 quarters · filed 2026-04-15 | 133.00 shares derived: sum of 4 quarters · filed 2026-04-15 | ||
| 2024-12-31 | -19.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -600.00 shares derived: sum of 2 quarters · filed 2026-04-15 | -331.00 shares derived: sum of 3 quarters · filed 2026-04-15 | 83.00 shares 10-K · filed 2026-04-15 | 1.56K shares 10-K · filed 2025-04-15 | |
| 2024-09-30 | 18.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 18.75K shares derived: sum of 2 quarters · filed 2024-11-14 | 19.16K shares 10-Q · filed 2024-11-14 | 13.90K shares derived: sum of 4 quarters · filed 2025-04-15 | ||
| 2024-06-30 | 269.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 683.00 shares 10-Q · filed 2024-08-14 | -4.58K shares derived: sum of 3 quarters · filed 2025-04-15 | |||
| 2024-03-31 | 414.00 shares 10-Q · filed 2024-05-15 | -4.85K shares derived: sum of 2 quarters · filed 2025-04-15 | ||||
| 2023-12-31 | -5.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 12.00 shares 10-K · filed 2025-04-15 | 393.00 shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 5.28K shares 10-Q · filed 2023-11-14 | |||||
| 2021-12-31 | 78.98K shares 10-Q · filed 2022-05-16 | 78.98K shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |